Genpact CEO Warns AI Will Reduce IT Workload and Jobs Cites Shift in Hiring Trends
Cancer Treatment Costs Soar ACAs Role Under Scrutiny as Expenses Reach Hundreds of Thousands
Fidelitys FHLC vs State Streets XLV A Comparative Analysis of Health Care ETFs
Chinas Energy Demand Resurgence Could Fuel Global Oil Price Volatility
Brigade Enterprises Expands in Hyderabad with Rs 850 Crore Housing Project
Quantum Computing Inc QUBT Navigates HighRisk HighReward Quantum Landscape
Stryker Corporation SYK Q1 2026 Earnings EPS Misses Estimates by 1375 Amid Market Headwinds
CLDX Q1 2026 Earnings Clinicalstage biotech reports widerthanexpected loss as pipeline investment continues
NTB Q1 2026 Earnings Strong EPS Beat Amid Quiet Revenue Disclosure Stock Edges Lower
GDS Q1 2026 Earnings Massive EPS Beat but Stock Slips on Revenue Uncertainty
HUN Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction
CCL Q1 2026 Earnings EPS Surprises to the Upside as Cruise Demand Holds Steady
JIN Medical International ZJYL Gains 371 as Shares Test Key Resistance at 250
Oak Woods Acquisition Warrants OAKUW Gain 311 to 002 A Tight Range at RockBottom Levels
SEALSQ Corp LAES Climbs 69 as Momentum Builds Above Key Support
Nextpower Inc NXT Edges Lower as Stock Consolidates Near Key Support Levels
Bluerock Acquisition Corp Unit BLRKU Steady at 1002 as Stock Holds Support
UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister
DOCS Q1 2026 Earnings Mixed Results as EPS Misses Estimates but Stock Rises
Ohio Valley Banc Corp OVBC Holds Steady Near Support as Volume Remains Tame
Brunswick Corporation BC Edges Higher as Marine Recreation Demand Stabilizes
COOTW Warrants Trade Near Penny Territory Shedding 35 Amid Thin Activity
Stifel Financial Holds Steady Near 7259 as Traders Eye Narrow Trading Range
Photronics PLAB Plunges Over 36 Key Support Levels in Focus
Neuphoria Therapeutics NEUP Soars 7 Key Levels to Watch After Bullish Breakout
Scorpio Tankers STNG Stock Dips 330 as Shipping Sector Faces Headwinds
Day One Biopharmaceuticals DAWN Holds Steady Consolidation Near Support Tests